1-ethyl-3-methylimidazolium diethylphosphate, 96.0%, 100g

3-(3,5-Dimethoxyphenyl)-1,2-oxazol-5-amine, 95+%, 250mg

3-bromo-1-methyl-1H-1,2,4-triazole-5-carbaldehyde, 1g

1-{2-[2-hydroxy-3-(propylamino)propoxy]phenyl}-3-phenylpropan-1-one hydrochloride, 98.0%, 250mg

Methyl-beta-cyclodextrin, min. 98%, 50 g, glass packaging

1-Phenyl-1H-pyrazol-3(2H)-one, 97.0%, 25g

3-Hydroxy-2-naphthonitrile, 97%, 1g

HSA-Gb31vial

(S,S)-2,2'-Isopropylidenebis(4-isopropyl-2-oxazoline)>98.0%(GC)250mg

2-Bromo-6-chlorothieno[2,3-b]pyridine, 95.0%, 1g

5-cyclobutyl-1,3,4-thiadiazol-2-amine, 95.0%, 1g

tert-Butyl 3-bromo-4-methyl-1H-indole-1-carboxylate, 95.0%, 1g

3-Methylpyridine-2-sulfonamide, 95.0%, 100mg